acrolein has been researched along with amphotericin b in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Giordani, R; Kaloustian, J; Portugal, H; Regli, P | 1 |
| Ahmad, I; Khan, MS | 1 |
3 other study(ies) available for acrolein and amphotericin b
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Potentiation of antifungal activity of amphotericin B by essential oil from Cinnamomum cassia.
Topics: Acrolein; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cinnamates; Cinnamomum aromaticum; Drug Synergism; Gas Chromatography-Mass Spectrometry; Microbial Sensitivity Tests; Oils, Volatile; Phytotherapy; Plant Extracts; Regression Analysis | 2006 |
Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms.
Topics: Acrolein; Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Synergism; Eugenol; Fluconazole; Humans; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Scanning; Plant Extracts; Staining and Labeling; Tetrazolium Salts | 2012 |